Approvals/TGA/XELJANZ tofacitinib (as citrate) 5 mg film-coated tablet blister pack

Approved

STANDARD

XELJANZ tofacitinib (as citrate) 5 mg film-coated tablet blister pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 02b3ea2bd87bc88a
Product Name: XELJANZ tofacitinib (as citrate) 5 mg film-coated tablet blister pack
Artg Id: 196987
Artg Name: XELJANZ tofacitinib (as citrate) 5 mg film-coated tablet blister pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2015-02-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01250-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01192-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

02b3ea2bd87bc88a

Type

Standard